| Name | cpda |
|---|---|
| Synonyms | N-[4-[(4-Chlorophenyl)methoxy]-2-pyridinyl]-2,6-difluoro-benzeneacetamide |
| Description | CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.Target: SHIP2in vitro: CPDA was found to enhance insulin signaling.in vivo: CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA was also found to improve the abnormal glucose metabolism in db/db mice. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C20H15ClF2N2O2 |
|---|---|
| Molecular Weight | 388.79500 |
| Exact Mass | 388.07900 |
| PSA | 51.22000 |
| LogP | 4.84640 |
| Storage condition | 2-8℃ |